| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7503321 | Drug and Alcohol Dependence | 2018 | 7 Pages |
Abstract
These findings support the validity and reliability of the ODAS as a tool to measure and assess buprenorphine dose adequacy in the context of an opioid dependency treatment program.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Francisco González-Saiz, Oscar Lozano Rojas, Joan Trujols, Saul Alcaraz, Núria Siñol, José Pérez de los Cobos, Buprenorphine Naloxone Survey Group Buprenorphine Naloxone Survey Group,